563results about How to "The dosage is easy to control" patented technology

The invention relates to a traditional Chinese medicine white wine medicament for effectively curing dermatopathy, which has the advantages of reasonable and scientific composing prescriptions, evident effect, convenient and hygienic employment, and is natural without hormones and chemical auxiliary agent, and is safe and reliable, and does not have side effect. The invention is made from raw material with the following part by weight, anoelica sinensis 8-10 parts by weight ( the following unit is the same), red peony root 6-10, chuanxiong rhizome 3-5, schizonepeta tenuifolia 3-5, coralbean bark 6, astragalus root 6-8, Chinese dittany bark 10-15, phillyrin 12-15, flavescent sophora root 15, honeysuckle flower 8-12, borneo camphor 3-5, radix salvia miltiorrhiza 9, frank incense 5, myrrh 5, and white wine 1.5-2, and the following operating procedures are concluded, the raw material except the borneo camphor, the frank incense, and the myrrh are positioned in a vessel and are filled with the white wine with the amount of 3-5cm higher than the medicine surface, and are sealed, and are opened and churned once a weak, and are immersed for three months in spring and two months in summer, and are filled with the frank incense and the myrrh one week before the employment, and can be employed when the medicine is filtered and is added with the borneo camphor.

The invention discloses a method for improving the uniformity of axial resistivity of czochralski silicon. The method comprises the steps as follows: (1) melting a polycrystalline silicon raw material and a solid doping agent in an argon atmosphere to obtain stable molten silicon; (2) introducing seed crystals into the stable molten silicon, and conducting constant diameter growth on the crystals after necking and shouldering processes; and (3) during the constant diameter growth period, adding dopant gas with the conductive type opposite to that of the solid doping agent until the growth of the czochralski silicon is fulfilled. According to the method, the type and the usage amount of the dopant gas are convenient to control, various required impurity concentration distributions can be obtained, the utilization rate of the czochralski silicon is increased, and the uniformity of the resistivity of the czochralski silicon is remarkably improved.

The invention provides an internet-based intelligent kitchen terminal product and a configuration method thereof. The product is characterized in that any one or more than one types of the following combinations from 1-1 to 1-5 and any one or more than one types of the following combinations from 1-6 to 1-9 are arranged on a terminal displayer; and the combinations from 1-1 to 1-5 include a display device used for guiding users to perform kitchen operation; built-in intelligent kitchen terminal application programs which are equipped with multiple input and output interfaces; multiple types of built-in wireless connecting modules; a processor; a memory; a power supply; a terminal display interface; and system programs. The combinations from 1-6 to 1-9 include multiple configured installing modes; and an intelligent kitchen terminal with an LED or liquid crystal display screen (LCD) for display, wherein the intelligent kitchen terminal includes any one of a square interface, a rectangular interface, a circular interface and an elliptical interface, and the boundary dimension has the appropriate size of length*width and at least covers or belongs to the range of 5.0-50cm*5.0-50cm.

The invention discloses a rapid diluting and mixing device for an agricultural agent. The rapid diluting and mixing device comprises a shell, a motor, a medicine kit and a base, wherein a horizontal rotating disk is fixed at the lower end of a transmission shaft; a vertical first stirring shaft is fixedly inserted into a first bearing; a plurality of horizontal stirring rods are fixed on the side wall of the first stirring shaft; a driven gear is meshed with a horizontal driving gear; a mixing blade is fixed at the lower end of a second stirring shaft; vertical connection openings are formed in a seal ring and a seal plate; a mobile regulating mechanism comprises a slide chute, a support rod, a mobile wheel, a threaded tube, a screw rod and a handle. The mixing blade and the stirring rods are driven to rotate simultaneously through the arranged turn plate, and internal different positions are stirred, so that the mixing effect of a liquid medicine is improved and the uniform mixing of the liquid medicine is ensured; and the liquid medicine in the medicine kit falls off through the rotating connection openings, the agent discontinuously falls off and the agent can be quickly mixed with water, so that the mixing efficiency is improved.

The invention discloses a preparation method of a photocatalyst based on monodisperse elemental bismuth and carbon nitride. The method comprises the following key steps: monodisperse elemental bismuth particles which are prepared through a liquid phase chemical reduction technology are immobilized on the surface of carbon nitride used as a carrier and prepared by using urea as a precursor, and a surfactant component in the above obtained composite system is removed through a coordination exchange reaction to obtain the elemental bismuth/carbon nitride photocatalyst. The preparation method of the elemental bismuth/carbon nitride photocatalyst has the advantages of simple process, low energy consumption, controllable material morphology and high reaction activity. The elemental bismuth/carbon nitride photocatalyst prepared in the invention can rapidly and effectively remove carbon monoxide and other pollutants in air, and the catalysis activity can be regulated through the controllable synthesis of the elemental bismuth.

The invention belongs to the technical field of biological medicine, and particularly relates to a three-function molecule combining CD19, CD3 and CD28 and application of the three-function molecule. The three-function molecule capable of identifying CD19, CD3 and CD28 simultaneously is constructed through a genetic engineering method and an antibody engineering method. In the aspects of a preparation technology and practical application, the molecule has the obvious advantages that the effect of activated T cells is further improved while the targeting property on CD19 positive cells is given to the T cells; when only CD19 is added, the bonding and killing effects of the CD19-mediated T cells on CD19 positive target cells are superior to those of an anti-CD19/anti-CD3 BiTE bispecific antibody, and the using convenience is superior to that of a CD19-targetted CAR-T technology.

The invention discloses a method for preparing dapoxetine hydrochloride. The method comprises the following steps: subjecting (s)-3-amino-3-phenylpropionic acid or an ester thereof to a reduction reaction in a reduction system prepared from a hydroborate and a boron trifluoride complex, so as to obtain an intermediate 1, i.e. (s)-3-amino-3-phenylpropanol; subjecting the (s) intermediate 1 to an Eschweiler-Clark reaction with formic acid and formaldehyde, so as to obtain an intermediate 2; subjecting the intermediate 2 to a Williamson ether forming reaction with 1-fluoronaphthalene, so as to obtain a free alkali, i.e. (s)-N,N-dimethyl-3-(1-naphthyloxy)phenyl propyl amine; subjecting the free alkali to a salt forming reaction with alcohol-acyl chloride or a chloride thereof, a hydrochloric acid organic solution or hydrochloric acid gas, thereby obtaining dapoxetine hydrochloride. According to the method, the synthesis route is low in production cost, the reaction conditions are mild, all the materials are readily available, the raw materials are low in toxicity, the reaction is simple in operation and high in safety, and the product is high in purity and yield and is environmentally friendly, so that the method is applicable to industrial large-scale production.

A Chinese medicine in the form of dripping pill for treating cold, fever, sore throat, etc is prepared from scutellaria root, forsythia fruit, isatis leaf and liquorice root.

The invention belongs to the technical field of plant growth regulators, and relates to a medicament composition being capable of controlling flourishing of plants and having a production increasing effect and application of the medicament composition. A plant growth regulator composition provided by the invention comprises the active ingredients of prohexadione calcium, paclobutrazol and a plant growth promoter, wherein the plant growth promoter is compound sodium nitrophenolate, diethyl aminoethyl hexanoate or gibberellin. 25% prohexadione calcium and paclobutrazol composite medicament wettable powder is used for controlling the flourishing of crops, and has the best effect when the dosage is 20g/acreage when being particularly used for controlling the flourishing of peanuts, soybeans or rapes. The plant growth regulator composition disclosed by the invention belongs to a ternary complex product, and compared with singly using prohexadione calcium to adjust the growth of the crops, the cost is greatly reduced, the dosage is easy to control, and the production increase of the crops is obvious; the safety is much higher than that of singly using paclobutrazol; compared with other triazole plant growth regulators for retarding plant growth, the plant growth regulator composition has the advantages of low residual toxicity, less dosage and environmental friendliness.

The invention provides a radioactive particle chain. The radioactive particle chain includes a soft tube having good histocompatibility and equivalent effects of radiotherapy tissue; one end of the soft tube is closed, and the other end of the soft tube is movably connected to a baffle sheet, wherein the area of the baffle sheet is greater than a cross sectional area of the soft tube; and radioactive particles are arranged in the soft tube. The radioactive particle chain can determine initial treatment dose through the characters of a tumor; periodic review is performed after the radioactive particles are arranged in the tumor; when the size of the tumor changes, the number of the radioactive particles can be increased or decreased by inserting or pulling out the radioactive particles, and then the dose of the radioactive particles can be controlled conveniently after the radioactive particles are implanted into the tumor; all the radioactive particles can be taken out when the tumor vanishes or a patient dies; and the complication can be reduced, and radiation to the patient or public can be decreased. The radioactive particles used in the patient can be disinfected and reused in tumors in other parts of the same patient after being taken out, and then medical resources can be saved, and the patient can accept the radioactive particles in mind.

The invention provides injection fleroxacin which is composed of fleroxacin, mannite and lactic acid; the invention also provides a preparation method of the fleroxacin freeze-dried powder: fleroxacin and mannite are added into water, then lactic acid is also dropped into the water, and the solution is stirred until the fleroxacin is dissolved completely; active carbon is added into the mixed solution which then is filtered; the filtrate is placed in a material disc of a freezedryer to be cooled slowly to 30DEG below zero to 60DEG below zero and be kept the prelimitary freezing for 2.5 to 3 hours at 30DEG below zero to 60DEG below zero, then is rapidly cooled to about 45DEG below zero to 55DEG below zero to be pumped to vacuum, is heated to 5DEG below zero to 5DEG for 12 to 15 hours and is kept at 5DEG below zero to 5DEG for 4 to 6 hours, is heated to 25DEG to 30DEG within 3 to 5 hours and is kept at 25DEG to 30DEG for 5 to 7 hours so that the fleroxacin freeze-dried powder is obtained. The obtained fleroxacin freeze-dried powder has simple components, favorable stability and resolubity and low water content.

The present invention relates to a kind of medicine composition, Lemai dripping pill, with functions of activating vital energy, promoting blood circulation, alleviating mental depression, removing blood stasis, nourishing blood and dredging blood vessel and for treating coronary heart disease, atherosclerosis, pulmonary heart disease, infarct dementia, etc. The present invention has high bioavailability, fast medicine release, fast acting, high effective content, taking convenience and low cost, and the production process has no pollution. The Lemai dripping pill is prepared with seven kinds of Chinese medicinal materials, including red sage, Chuanxiong rhizome, red peony root, safflower, etc. and medicine carrier as matrix.

The invention relates to a polymer coagulant which contains the following components by weight percent: 5%-25% of anionic polyacrylamide, 5%-25% of cationic polyacrylamide, 5%-25% of non-ionic polyacrylamide, 3%-15% of dispersant and 40%-60% of water. The polymer coagulant is in solution state, and the range of pH value is 6.5-7.5; and the polyacrylamide is a water-soluble substance with a net structure. The polymer coagulant provided by the invention can be used in sewage treatment with larger change range of pH value and has high treatment efficiency and significant effects, and the clarity of water after the treatment is high; the polymer coagulant is in the solution state, has stable performances and can be configured to be the solution with very low concentration, the solution can not be degraded, the dosing quantity is convenient to control, when in use, the long-term dispersion and the stirring are unnecessary, the polymer coagulant can be used anytime and anywhere, and the operation is safe and convenient; and the polymer coagulant can be preserved for a long time, and the production cost can be reduced.

The invention discloses a medicinal composition for treating urinary lithiasis, pyelonephritis and cholecystitis, especially snowbell-leaf tickclover dripping pills and its preparation method, wherein the dripping pills are prepared from snowbell-leaf tickclover, and medicinal carrying agent as the base material. The dripping pills have the advantages of high biological availability, quick-speed medicine release, quick-speed effect, higher medicinal content, easy administering, low price, and no contamination in production.

The invention relates to a Lllicium henryi drop pill, which is a medicinal composition having the functions of repercussion, removing stasis, promoting blood circulation, relieving pain, treating waist and knee strain, articular muscle desmodynia and rheumatalgia. The aim of the invention is to provide a medicinal composition having the advantages of high biological availability, quick-speed medicine release, quick-speed effect, higher medicinal content, accurate administration dosage, low price, no acute allergic reaction or adverse effect, and facilitated transportation and carrying. The drop pill is prepared from traditional Chinese herb of Lllicium henryi as raw material, and medicinal carrying agent as the base material.

The invention provides a preparation method of hydroxyl-terminated polymethylphenyl siloxane with controllable viscosity, which comprises the following steps: A) mixing methylphenylcyclosiloxane and methylcyclosiloxane, and dehydrating under vacuum conditions to obtain a dehydrated material; B) adding a double-hydroxy-terminated siloxane end-capping agent and a basic catalyst into the dehydrated material, heating to 90-110 DEG C, reacting for 3-6 hours, continuously heating to 120-160 DEG C, and introducing nitrogen to break the medium, with the dosage of the double-hydroxyl-terminated siloxane end-capping reagent calculated according to a formula (1) and accounting for 0.05%-5% of the total weight of the ring body; and C) removing low-boiling-point substances in the reaction product obtained in the step B) under a vacuum condition to obtain the viscosity-controllable hydroxyl-terminated polymethylphenyl siloxane with the structure shown in the formula I. The preparation method solvesthe problem of poor compatibility between the end-capping agent and the raw material, and finally, realizes the controllable viscosity of a methylphenyl 108 adhesive.

A dripping pill of bigelietong hydrochloride for treating diabetes is prepared from the bigelietong hydrochloride and the pharmacologically acceptable carrier.

The invention discloses a method for preparing an asphalt micro-meso analysis sample by adopting a silicone mold. According to the technical scheme, the method comprises the steps of preparing a mold; heating and pouring; scraping by utilizing a heat knife; carrying out secondary heating; fixing a mold glass slide; cooling and demolding; testing and observing. The mold is prepared by utilizing the characteristics of no toxicity, no odor, stable chemical property, good elasticity, high tensile strength, high temperature resistance, easiness in forming and demolding, and the like of silicon, the prepared analysis sample has a smooth surface, is high in flatness and uniform in thickness, various analysis samples meeting different requirements can be obtained by adjusting the shape, specification and size of a sample preparation mold, so that the specification requirement of test instruments such as a scanning electron microscope, an atomic force microscope and the like for different analysis samples can be met. According to the method, the operation is convenient, the analysis sample forming efficiency is high, the consumption of asphalt is controllable, and the method is ideal for preparing the asphalt micro-meso analysis sample.